TY - JOUR
T1 - Clinical presentation of Nipah virus infection in Bangladesh
AU - Hossain, M. Jahangir
AU - Gurley, Emily S.
AU - Montgomery, Joel M.
AU - Bell, Michael
AU - Carroll, Darin S.
AU - Hsu, Vincent P.
AU - Formenty, P.
AU - Croisier, A.
AU - Bertherat, E.
AU - Faiz, M. A.
AU - Azad, Abul Kalam
AU - Islam, Rafiqul
AU - Molla, M. Abdur Rahim
AU - Ksiazek, Thomas G.
AU - Rota, Paul A.
AU - Comer, James A.
AU - Rollin, Pierre E.
AU - Luby, Stephen P.
AU - Breiman, Robert F.
PY - 2008/4/1
Y1 - 2008/4/1
N2 - Background. In Bangladesh, 4 outbreaks of Nipah virus infection were identified during the period 2001-2004. Methods. We characterized the clinical features of Nipah virus-infected individuals affected by these outbreaks. We classified patients as having confirmed cases of Nipah virus infection if they had antibodies reactive with Nipah virus antigen. Patients were considered to have probable cases of Nipah virus infection if they had symptoms consistent with Nipah virus infection during the same time and in the same community as patients with confirmed cases. Results. We identified 92 patients with Nipah virus infection, 67 (73%) of whom died. Although all age groups were affected, 2 outbreaks principally affected young persons (median age, 12 years); 62% of the affected persons were male. Fever, altered mental status, headache, cough, respiratory difficulty, vomiting, and convulsions were the most common signs and symptoms; clinical and radiographic features of acute respiratory distress syndrome of Nipah illness were identified during the fourth outbreak. Among those who died, death occurred a median of 6 days (range, 2-36 days) after the onset of illness. Patients who died were more likely than survivors to have a temperature >37.8°C, altered mental status, difficulty breathing, and abnormal plantar reflexes. Among patients with Nipah virus infection who had well-defined exposure to another patient infected with Nipah virus, the median incubation period was 9 days (range, 6-11 days). Conclusions. Nipah virus infection produced rapidly progressive severe illness affecting the central nervous and respiratory systems. Clinical characteristics of Nipah virus infection in Bangladesh, including a severe respiratory component, appear distinct from clinical characteristics reported during earlier outbreaks in other countries.
AB - Background. In Bangladesh, 4 outbreaks of Nipah virus infection were identified during the period 2001-2004. Methods. We characterized the clinical features of Nipah virus-infected individuals affected by these outbreaks. We classified patients as having confirmed cases of Nipah virus infection if they had antibodies reactive with Nipah virus antigen. Patients were considered to have probable cases of Nipah virus infection if they had symptoms consistent with Nipah virus infection during the same time and in the same community as patients with confirmed cases. Results. We identified 92 patients with Nipah virus infection, 67 (73%) of whom died. Although all age groups were affected, 2 outbreaks principally affected young persons (median age, 12 years); 62% of the affected persons were male. Fever, altered mental status, headache, cough, respiratory difficulty, vomiting, and convulsions were the most common signs and symptoms; clinical and radiographic features of acute respiratory distress syndrome of Nipah illness were identified during the fourth outbreak. Among those who died, death occurred a median of 6 days (range, 2-36 days) after the onset of illness. Patients who died were more likely than survivors to have a temperature >37.8°C, altered mental status, difficulty breathing, and abnormal plantar reflexes. Among patients with Nipah virus infection who had well-defined exposure to another patient infected with Nipah virus, the median incubation period was 9 days (range, 6-11 days). Conclusions. Nipah virus infection produced rapidly progressive severe illness affecting the central nervous and respiratory systems. Clinical characteristics of Nipah virus infection in Bangladesh, including a severe respiratory component, appear distinct from clinical characteristics reported during earlier outbreaks in other countries.
UR - http://www.scopus.com/inward/record.url?scp=42549092343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42549092343&partnerID=8YFLogxK
U2 - 10.1086/529147
DO - 10.1086/529147
M3 - Article
C2 - 18444812
AN - SCOPUS:42549092343
SN - 1058-4838
VL - 46
SP - 977
EP - 984
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 7
ER -